Australia markets open in 6 hours 27 minutes

Dare Bioscience Inc (1221.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.3840-0.0325 (-7.80%)
At close: 08:04AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-28,874
-30,161
-30,948
-38,696
-27,401
-
Depreciation & amortisation
39.633
38.363
24.202
26.413
43.227
-
Stock-based compensation
2,534
2,531
2,159
1,600
742.031
-
Change in working capital
-4,042
-11,343
10,700
8,728
1,543
-
Accounts payable
1,345
1,358
-75.132
1,082
-61.85
-
Other working capital
-30,189
-39,486
-18,151
-28,779
-25,253
-
Other non-cash items
191.047
78.316
-23.062
-51.846
-162.167
-
Net cash provided by operating activities
-29,552
-38,857
-18,088
-28,764
-25,235
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-629.43
-63.069
-14.524
-17.625
-
Acquisitions, net
-
-
-
-
-
0
Net cash used for investing activities
-636.726
-629.43
-63.069
-14.524
-17.625
-
Cash flows from financing activities
Debt repayment
-534.376
-333.985
0
-
-
-
Common stock issued
9,562
9,347
1,219
75,314
22,977
-
Other financing activities
-
4,724
-
-
-
-
Net cash used provided by (used for) financing activities
14,352
15,637
1,343
75,847
25,131
-
Net change in cash
-15,864
-23,859
-17,004
47,005
-110.64
-
Cash at beginning of period
19,829
34,670
51,674
4,669
4,780
-
Cash at end of period
3,992
10,811
34,670
51,674
4,669
-
Free cash flow
Operating cash flow
-29,552
-38,857
-18,088
-28,764
-25,235
-
Capital expenditure
-
-629.43
-63.069
-14.524
-17.625
-
Free cash flow
-30,189
-39,486
-18,151
-28,779
-25,253
-